We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Subpopulation of Fibroblasts Drives Breast Tumor Development

By LabMedica International staff writers
Posted on 03 Dec 2018
Print article
Image: A mouse breast tumor that contains bone marrow-derived fibroblasts (red) as well as other cancer-associated fibroblasts (green) (Photo courtesy of Raz et al., 2018).
Image: A mouse breast tumor that contains bone marrow-derived fibroblasts (red) as well as other cancer-associated fibroblasts (green) (Photo courtesy of Raz et al., 2018).
Breast tumors with reduced levels of the enzyme platelet-derived growth factor alpha (PDGFRalpha), which is caused by recruitment of a distinct subpopulation of bone marrow-derived cancer-associated fibroblasts, have been linked to a worse prognosis for the patient.

Solid tumors contain large numbers of fibroblast cells that promote cancer cell proliferation, inflammation, and the formation of new blood vessels to supply the growing tumor with nutrients and oxygen. Cancer-associated fibroblasts (CAFs) are especially prominent in breast tumors, but the nature of their function and origin not been unresolved completely. To clarify these issues, investigators at Tel Aviv University (Israel) performed adoptive BM (bone marrow) transplantations in newly generated transgenic mice.

They reported in the November 23, 2018, online edition of the Journal of Experimental Medicine that in the transgenic mouse model of human breast cancer development, BM-derived mesenchymal stromal cells (MSCs) were recruited to primary breast tumors and to lung metastases and differentiated to a distinct subpopulation of CAFs. Detailed analysis of this distinct CAF population revealed that BM-derived CAFs did not express the receptor for PDGFRalpha, which was previously shown to be a robust marker of fibroblasts. Consequently, recruitment of BM-derived CAFs to primary tumors and metastases resulted in a gradual decrease in PDGFRalpha levels, which was evident also in human breast tumors, and correlated with worse outcome.

The finding that PDGFRalpha expression distinguishes two functionally unique CAF populations may have implications for patient diagnosis and tailored therapeutics in breast cancer.

"Our study shows that the recruitment of bone marrow-derived fibroblasts is important for promoting tumor growth, likely by enhancing blood vessel formation," said senior author Dr. Neta Erez, professor of pathology at Tel Aviv University. "Understanding the function of these cancer-associated fibroblasts could form the basis of developing novel therapeutic manipulations that co-target bone marrow-derived fibroblasts as well as the cancer cells themselves."

Related Links:
Tel Aviv University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.